SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial - Rothschild, SI; Zippelius, A; Eboulet, EI (J Clin Oncol, 2021)
et al.